Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 in Relapsed or Refractory Thymomas
NCT02220855Phase 2Completed
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buparlisib in thymoma. Started Oct 2014; status: completed.
02
Drugs
buparlisib
03
Conditions
thymoma
Beyond the preview
Go deeper on NCT02220855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02220855.